High expression level of bone degrading proteins as a possible inducer of osteolytic features in pigmented villonodular synovitis

Cancer Letters

Volumn 255, Issue 2, 2007, Pages 275-283

  Geldyyev, Aman ^a   Koleganova, Nadezda ^a   Piecha, Grzegorz ^a   Sueltmann, Holger ^b   Finis, Katharina ^b   Ruschaupt, Markus ^b   Poustka, Annemarie ^b   Gross, Marie Luise ^a   Berger, Irina ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Bone sialoprotein; Osteopontin; PVNS; RANKL

Indexed keywords

BONE SIALOPROTEIN; COMPLEMENTARY DNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OSTEOARTHRITIS; OSTEOLYSIS; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TISSUE MICROARRAY;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOLYSIS; OSTEOPONTIN; OSTEOPROTEGERIN; RANK LIGAND; RNA; SIALOGLYCOPROTEINS; SYNOVITIS, PIGMENTED VILLONODULAR; TISSUE ARRAY ANALYSIS;

EID: 34547935548     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.05.003     Document Type: Article

References (20)

1. West R.B., Rubin B.P., Miller M.A., et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc. Natl. Acad. Sci. USA 103 (2006) 690-695
2. Bertoni F., Unni K.K., Beabout J.W., et al. Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am. J. Surg. Pathol. 21 (1997) 153-163
3. Flandry F., Hughston J.C., McCann S.B., et al. Diagnostic features of diffuse pigmented villonodular synovitis of the knee. Clin. Orthop. Relat. Res. (1994) 212-220
4. Fassbender H.G. Pathology and Pathobiology of Rheumatic Diseases (2002), Heidelberg, Springer, Berlin
5. Berger I., Weckauf H., Helmchen B., et al. Rheumatoid arthritis and pigmented villonodular synovitis: comparative analysis of cell polyploidy, cell cycle phases and expression of macrophage and fibroblast markers in proliferating synovial cells. Histopathology 46 (2005) 490-497
6. Finis K., Sultmann H., Ruschhaupt M., et al. Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches. Arthritis. Rheum. 54 (2006) 1009-1019
7. Jones D.H., Nakashima T., Sanchez O.H., et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440 (2006) 692-696
8. Natasha T., Kuhn M., Kelly O., et al. Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone. Am. J. Pathol. 168 (2006) 551-561
9. Sambrook J., and Russel D.W. Molecular Cloning: A Laboratory Manuel. 3rd ed. (2001), Cold Spring Harbor Laboratory Press, New York
10. Van Gelder R.N., von Zastrow M.E., Yool A., et al. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. USA 87 (1990) 1663-1667
11. Huber W., von Heydebreck A., Sultmann H., et al. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 Suppl 1 (2002) 96-104
12. Ihaka R. A language for data analysis and graphics. J. Comp. Graph. Stat. 5 (1996) 299-314
13. Guise T.A. Parathyroid hormone-related protein and bone metastases. Cancer 80 (1997) 1572-1580
14. Neumann E., Gay S., and Muller-Ladner U. The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: new insights from animal models. Arthritis Rheum. 52 (2005) 2960-2967
15. Pettit A.R., Walsh N.C., Manning C., et al. Rheumatology (Oxford) (2006)
16. Karadag A., Ogbureke K.U., Fedarko N.S., et al. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion. J. Natl. Cancer Inst. 96 (2004) 956-965
17. Chabas D. Osteopontin, a multi-faceted molecule. Med. Sci. (Paris) 21 (2005) 832-838
18. Otsuki T., Yamada O., Kurebayashi J., et al. Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells. Leuk. Lymphoma 41 (2001) 397-409
19. Tenta R., Sourla A., Lembessis P., et al. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells. Anticancer Res. 26 (2006) 283-291
20. Buzi F., Maccarinelli G., Guaragni B., et al. Serum osteoprotegerin and receptor activator of nuclear factors κB (RANKL) concentrations in normal children and in children with pubertal precocity, Turner's syndrome and rheumatoid arthritis. Clin. Endocrinol. (Oxf) 60 (2004) 87-91